Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups

  • Qi Jin
  • , Roderick S. Davis
  • , Ann M. Bullion
  • , Jian Jin
  • , Yonghui Wang
  • , Katherine L. Widdowson
  • , Michael R. Palovich
  • , James J. Foley
  • , Dulcie B. Schmidt
  • , Peter T. Buckley
  • , Edward F. Webb
  • , Michael Salmon
  • , Kristen E. Belmonte
  • , Henry M. Sarau
  • , Jakob Busch-Petersen

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Tyrosine ureas had been identified as potent muscarinic receptor antagonists with promising in vivo activity. Controlling the stereochemistry of the chiral quaternary ammonium center had proved to be a serious issue for this series, however. Herein we describe the preparation and SAR of tyrosine urea antagonists containing achiral quaternary ammonium centers. The most successful such moiety was the 2-methylimidazo[2,1-b][1,3]thiazol-7-ium group which yielded highly potent antagonists with long duration of action in an inhaled animal model of bronchoconstriction.

Original languageEnglish
Pages (from-to)7087-7091
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume22
Issue number23
DOIs
StatePublished - 1 Dec 2012
Externally publishedYes

Keywords

  • Airway disease
  • Inhaled
  • Muscarinic antagonists
  • Quaternary ammonium salts
  • Solid phase synthesis

Fingerprint

Dive into the research topics of 'Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups'. Together they form a unique fingerprint.

Cite this